Oklahoma City Hospital Pays $120,000 to Settle Civil Penalty Claims
Stemming from the Alleged Failure to Timely Report Thefts of Fentanyl and Hydromorphone
OKLAHOMA CITY, OK – INTEGRIS ProHealth, Inc., and its parent, INTEGRIS Health, Inc. (collectively, “INTEGRIS”) paid $120,000 to settle civil penalty claims stemming from allegations that Integris Baptist Medical Center Pharmacy (“Integris Pharmacy”), which is owned and operated by INTEGRIS ProHealth, Inc., violated the Comprehensive Drug Abuse Prevention and Control Act of 1970 and its regulations, announced Special Agent in Charge Eduardo A. Chávez.
The United States alleges that in October 2021 Integris Pharmacy failed to timely notify DEA regarding thefts or significant losses of Schedule II controlled substances. More specifically, Integris Pharmacy allegedly failed to report within one business day of discovery the thefts of fentanyl and hydromorphone by a former employee. To resolve these allegations, INTEGRIS agreed to pay $120,000 to the United States.
In reaching this settlement, INTEGRIS did not admit liability, and the government did not make any concessions about the legitimacy of the claims. The agreement allows the parties to avoid the delay, expense, inconvenience, and uncertainty involved in litigating the case.
This case was investigated by the Drug Enforcement Administration Oklahoma City Diversion Group, Assistant U.S. Attorneys Amanda R. Johnson and Ronald R. Gallegos prosecuted the case.
